Haemoglobin-based erythrocyte transfusion substitutes

Bibliography

• WALLACE EL, SURGENOR DM, HAO HS, AN J, CHAPMAN RH, CHURCHILL WH: Collection and transfusion of blood and blood components in the United States, 1989. Transfusion (1993) 33(2):139–144.
   PubMed Web of Science ®Google Scholar
• VAMVAKAS EC: Epidemiology of red blood cell utilization. Transfus. Med. Rev (1996) 10(1):44–61.
   PubMed Web of Science ®Google Scholar
• VAMVAKAS EC, TASWELL HF: Epidemiology of blood transfusion. Transfusion (1994) 34(6):464–470.
   PubMed Web of Science ®Google Scholar
• DONAHUE JG, MUNOZ A, NESS PM et al.: The declining risk of post-transfusion hepatitis C virus infection. N Engl. j Med. (1992) 327(6):369–373.
   PubMed Web of Science ®Google Scholar
• GOODNOUGH LT, BRECHER ME, KANTER MH, AUBUCHON JP: Transfusion medicine. First of two parts - blood transfusion. N Engl. j Med. (1999) 340(6)438–447.
   Google Scholar
• GLÜCK D, KUBANEK B, MAURER C, PETERSEN N: Seroconversion of HIV, HCV, and HBV in blood donors in 1996 - risk of virus transmission by blood products in Germany. Infusionsther. Transfusionsmed. (1998) 25:82–84.
   Google Scholar
• NUCCI ML, ABUCHOWSKI A: The search for blood substitutes. Sri. Am. (1998) 278(2):72–77.
   Google Scholar
• BAELE PL, DE BRUYERE M, DENEYS V et al: Bedside transfusion errors. A prospective survey by the Belgium SAnGUIS Group. Vox Sang (1994) 66(2):117–121.
   PubMed Web of Science ®Google Scholar
• COHN SM: The current status of haemoglobin-based blood substitutes. Ann. Med. (1997) 29(5):371–376.
   PubMed Web of Science ®Google Scholar
• BLUT A: Parvovirus B19. Infusionsther. Transfusions. (1998) 25\(Suppl. 1):97–102.
   Google Scholar
• LANDERS DF, HILL GE, WONG KC, FOX IJ: Blood transfusion-induced immunomodulation. Arresth. Arralg. (1996) 82(1):187–204.
   PubMed Web of Science ®Google Scholar
• ••This article gives an overview of thepossible immunomodulating side effects of allogeneic blood products.
   Google Scholar
• HEISS MM, MEMPEL W, JAUCH KW et al.: Beneficial effect of autologous blood transfusion on infectious complications after colorectal cancer surgery. Lancet (1993) 342(8883):1328–1333.
   PubMed Web of Science ®Google Scholar
• BLUMBERG N, AGARWAL MM, CHUANG C: Relation between recurrence of cancer of the colon and blood transfusion. Br Med. j (Gun. Res. Ed.) (1985) 290(6474):1037–1039.
   PubMed Web of Science ®Google Scholar
• HEBERT PC, WELLS G, BLAJCHMAN MA et al: A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group [see comments] [published erratum appears in N Engl. J. Med. 1999 340(13):10561. N Engl. J. Med. (1999) 340(6):409–17.
   Google Scholar
• FEOLA M, SIMONI J, DOBKE M, CANIZARO PC: Complement activation and the toxicity of stroma-free hemoglobin solutions in primates. Circ. Shock (1988) 25(4):275–290.
   PubMedGoogle Scholar
• FRIEDMAN HI, DEVENUTO F, ZUCK TF, MELLICK E LOLLINI L: Histologic and ultrastructural effects of stroma-free hemoglobin solutions on rat liver, kidney, and brain. Surg. Forum (1977) 28:3–5.
   PubMedGoogle Scholar
• MOSS GS, DEWOSKIN R, COCHIN A: Stroma-free hemoglobin. I. Preparation and observations on in vitro changes in coagulation. Surgery (1973) 74(2):198–203.
   Google Scholar
• SELLARDS A, MINOT G: Injection of Haemoglobin in man and its relatin to blood destruction, with especial reference to the anaemias. J. Med. Res. (1916) 34:469–494.
   PubMedGoogle Scholar
• SAVITSKY JP, DOCZI J, BLACK J, ARNOLD JD: A clinical safety trial of stroma-free hemoglobin. Chu. Pharmacol Ther. (1978) 23(1):73–80.
   PubMed Web of Science ®Google Scholar
• LEER, ATSUMI N, JACOBS EE, AUSTEN WG, VLAHAKES GJ: Ultrapure, stroma-free, polymerized bovine hemoglobin solution: evaluation of renal toxicity. J. Surg. Res. (1989) 47(5):407–411.
   PubMed Web of Science ®Google Scholar
• LIPFERT B, STANDL T, DULLMANN J, HELMCHEN U, SCHULTE AM ESCH J, LORKE DE: Histology and ultrastructure of liver and kidney following blood exchange with ultrapurified, polymerised bovine hemoglobin in comparison with hydroxyethyl starch. Lab. Invest. (1999) 79(5):573–582.
   PubMed Web of Science ®Google Scholar
• STANDL T, BURMEISTER MA, HORN EP WILHELM S, KNOEFEL WT, SCHULTE AM ESCH J: Bovine haemoglobin-based oxygen carrier for patients undergoing haemodilution before liver resection. Br j Armes& (1998) 80(2):189–194.
   Web of Science ®Google Scholar
• •Effects of a moderate haemodilution with bovine polymerised cell-free haemoglobin on haematology, oximetry, coagulation profiles and blood chemistry are examined in patients undergoing liver resection.
   Google Scholar
• LIEBERTHAL W, FUHRO R, ANDRY C, VALERI CR: Effects of hemoglobin-based oxygen-carrying solutions in anesthetized rats with acute ischemic renal failure. j Lab. Chu. Med. (2000) 135(1):73–81.
   PubMedGoogle Scholar
• HUGHES GS, ANTAL EJ, LOCKER PK, FRANCOM SF, ADAMS WJ, JACOBS EE: Physiology and pharmacokinetics of a novel hemoglobin-based oxygen carrier in humans. Grit. Care Med. (1996) 24(5):756–764.
   PubMed Web of Science ®Google Scholar
• SONG D, OLANO M, WILSON DF et al.: Comparison of the efficacy of blood and polyethylene glycol-hemoglobin in recovery of newborn piglets from hemorrhagic hypotension: effect on blood pressure, cortical oxygen, and extracellular dopamine in the brain. Transfusion (1995) 35(7):552–558.
   PubMed Web of Science ®Google Scholar
• URBAITIS BK, RAZYNSKA A, CORTEZA Q, FRONTICELLI C, BUCCI E: Intravascular retention and renal handling of purified natural and intramolecularly cross-linked hemoglobins. Lab. Chu. Med. (1991) 117(2):115–121.
   PubMed Web of Science ®Google Scholar
• LOOKER D, ABBOTT-BROWN D, COZART P et al: A human recombinant haemoglobin designed for use as a blood substitute. Nature (1992) 356(6366)258–260.
   Google Scholar
• CHANG T: Semipermeable microcapsules. Science (1964) 146:524–525.
   PubMed Web of Science ®Google Scholar
• FRONTICELLI C, BUCCI E, ORTH C: Solvent regulation of oxygen affinity in hemoglobin. Sensitivity of bovine hemoglobin to chloride ions. j Biol. Chem. (1984) 259(17):10841–10844.
   Google Scholar
• D'AGNILLO F, CHANG TM: Polyhemoglobin-superoxide dismutase-catalase as a blood substitute with antioxidant properties. Nature Biotechnol (1998) 16(7):667–671.
   PubMed Web of Science ®Google Scholar
• ZUCKERMAN SH, DOYLE MP, GORCZYNSKI R, ROSENTHAL GJ: Preclinical biology of recombinant human hemoglobin, rHb1.1. Artif Cells Blood Substit. Immobil Biotechnol (1998) 26(3):231–257.
   Google Scholar
• DIERYCK W, PAGNIER J, POYART C et al.: Human haemoglobin from transgenic tobacco. Nature (1997) 386(6620):29–30.
   PubMed Web of Science ®Google Scholar
• SWANSON ME, MARTIN MJ, O'DONNELL JK et al: Production of functional human hemoglobin in transgenic swine. Biotechnology (NY) (1992) 10(5):557–559.
   PubMedGoogle Scholar
• KUMAR R: Recombinant hemoglobins as blood substitutes: a biotechnology perspective. Proc. Soc. Exp. Biol. Med. (1995) 208(2):150–158.
   PubMed Web of Science ®Google Scholar
• VLAHAKES GJ, LEER, JACOBS EE, LARAIA PJ, AUSTEN WG: Hemodynamic effects and oxygen transport properties of a new blood substitute in a model of massive blood replacement. Thome. Cardiovasc. Surg. (1990) 100(3):379–388.
   Web of Science ®Google Scholar
• •Nearly complete blood exchange with bovine haemoglobin in sheep provided stable haemodynamics and survival of all animals under the condition of two additional infusions of HBOC on days 2 and 4 after exchange.
   Google Scholar
• BOSMAN RJ, MINTEN J, LU HR, VAN AIKEN H, FLAMENG W: Free polymerized hemoglobin versus hydroxyethyl starch in resuscitation of hypovolemic dogs. Arresth. Arialg. (1992) 75(5):811–817.
   PubMed Web of Science ®Google Scholar
• HARRINGER W, HODAKOWSKI GT, SVIZZERO T, JACOBS EE, JR., VLAHAKES GJ: Acute effects of massive transfusion of a bovine hemoglobin blood substitute in a canine model of hemorrhagic shock. Eur. Cardiothorac. Surg. (1992) 6(12):649–654 (discussion 654).
   Google Scholar
• RABINOVICI R, RUDOLPH AS, LIGLER FS, SMITH EF, FEUERSTEIN G: Biological responses to exchange transfusion with liposome-encapsulated hemoglobin. Circ. Shock (1992) 37(2):124–133.
   PubMedGoogle Scholar
• SIEGEL JH, FABIAN M, SMITH JA, COSTANTINO D: Use of recombinant hemoglobin solution in reversing lethal hemorrhagic hypovolemic oxygen debt shock. J. Trauma (1997) 42(2):199–212.
   PubMed Web of Science ®Google Scholar
• STANDL TG, REEKER W, REDMANN G, KOCHS E, WERNER C, SCHULTE AM ESCH J: Haemodynamic changes and skeletal muscle oxygen tension during complete blood exchange with ultrapurified polymerized bovine haemoglobin. Intensive Care Med. (1997) 23(8):865–872.
   PubMed Web of Science ®Google Scholar
• •Nearly complete blood exchange with polymerised bovine haemoglobin provided haemodynamic stability and increased skeletal muscle tissue oxygen tensions in dogs.
   Google Scholar
• CONOVER CD, LINBERG R, SHUM KL, SHORR RG: The ability of polyethylene glycol conjugated bovine hemoglobin (PEG-Hb) to adequately deliver oxygen in both exchange transfusion and top-loaded rat models. Artif Cells Blood Substit. Immobil Biotechnol (1999) 27(2):93–107.
   PubMed Web of Science ®Google Scholar
• SOLTERO RG, HANSBROUGH JF: The effects of diaspirin cross-linked hemoglobin on hemodynamics, metabolic acidosis, and survival in burned rats. j Trauma (1999) 46(2):286–291.
   PubMed Web of Science ®Google Scholar
• MANNING JE, KATZ LM, BROWNSTEIN MR, PEARCE LB, GAWRYL MS, BAKER CC: Bovine hemoglobin-based oxygen carrier (HBOC-201) for resuscitation of uncontrolled, exsanguinating liver injury in swine. Carolina Resuscitation Research Group. Shock (2000) 13(2):152–159.
   Google Scholar
• CONOVER CD, LINBERG R, LEJEUNE L, NAGY M, SHUM KL: PEG-Hemoglobin as a resuscitation solution in the treatment of hypovolemic shock in the anesthetized rat. Artif Owns (1999) 23(12):1088–1098.
   PubMed Web of Science ®Google Scholar
• STANDL T, HORN P, WILHELM S et al:Bovine haemoglobin is more potent than autologous red blood cells in restoring muscular tissue oxygenation after profound isovolaemic haemodilution in dogs [see comments]. Can. j Anaesth. (1996) 43(7):714–23.
   PubMed Web of Science ®Google Scholar
• ••Stepwise transfusion with bovine cell-freehaemoglobin, autologous packed red cells or freshly donated red blood cells after profound isovolaemic haemodilution in dogs provided restoration of muscular tissue oxygen tensions with a significantly lower dose of HBOC when compared with cellular haemoglobin indicating a higher oxygenation potential of HBOC.
   Google Scholar
• CRAGO MS, WEST SD, MCKENZIE JE: Effects of diaspirin crosslinked hemoglobin infusion in treadmill-exercised swine. Heart Vessels (1999) 14(1):1–8.
   PubMed Web of Science ®Google Scholar
• PAGE TC, LIGHT WR, MCKAY CB, HELLUMS JD: Oxygen transport by erythrocyte/hemoglobin solution mixtures in an in vitro capillary as a model of hemoglobin-based oxygen carrier performance. Microvasc. Res. (1998) 55(1):54–64.
   PubMed Web of Science ®Google Scholar
• ••This in vitro study shows that smallamounts of extracellular haemoglobin significantly enhance the oxygen off-load from suspensions of red cells and HBOC.
   Google Scholar
• ROONEY MW, HIRSCH LJ, MATHRU M: Hemodilution with oxyhemoglobin. Mechanism of oxygen delivery and its superaugmentation with a nitric oxide donor (sodium nitroprusside). Anesthesiology (1993) 79(1):60–72.
   Google Scholar
• ••The study shows that one importantmechanism of HBOC-associated vasoconstriction is binding of endothelium-derived NO, and that this haemodynamic side effect can be reversed by NO-donors.
   Google Scholar
• SCHULTZ SC, GRADY B, COLE E HAMILTON I, BURHOP K, MALCOLM DS: A role for endothelin and nitric oxide in the pressor response to diaspirin cross-linked hemoglobin. j Lab. Clin. Med. (1993) 122(3):301–308.
   PubMed Web of Science ®Google Scholar
• SHARMA AC, GULATI A: Yohimbine modulates diaspirin crosslinked hemoglobin-induced systemic hemodynamics and regional circulatory effects. Grit. Care Med. (1995) 23(5):874–884.
   PubMed Web of Science ®Google Scholar
• MAXWELL RA, GIBSON JB, FABIAN TC, PROCTOR KG: Resuscitation of severe chest trauma with four different hemoglobin-based oxygen-carrying solutions. j Trauma (2000) 49(2):200–209 (discussion 209–211).
   Google Scholar
• LIEBERTHAL W, FUHRO R, FREEDMAN JE, TOOLAN G, LOSCALZO J, VALERI CR: 0-raffinose cross-linking markedly reduces systemic and renal vasoconstrictor effects of unmodified human hemoglobin. I Pharmacol Esp. Ther. (1999) 288(3):1278–1287.
   PubMed Web of Science ®Google Scholar
• •Chemically modified cell-free haemoglobin showed a significantly decreased nephrotoxic potential and did not exacerbate renal injury after ischaemia and reperfusion.
   Google Scholar
• BUEHLER PW, MEHENDALE S, WANG H et al.: Resuscitative effects of polynitroxylated alphaalpha-cross-linked hemoglobin following severe hemorrhage in the rat. Free Radic. Biol. Med. (2000) 29(8):764–774.
   PubMed Web of Science ®Google Scholar
• ALAYASH Al: Hemoglobin-based blood substitutes and the hazards of blood radicals. Free Radic. Res. (2000) 33(4):341–348.
   PubMed Web of Science ®Google Scholar
• HESS JR, MACDONALD VW, BRINKLEY WW: Systemic and pulmonary hypertension after resuscitation with cell-free hemoglobin. j Appl. Physiol (1993) 74(4):1769–1778.
   PubMed Web of Science ®Google Scholar
• GULATI A, SHARMA AC, BURHOP KE: Effect of stroma-free hemoglobin and diaspirin cross-linked hemoglobin on the regional circulation and systemic hemodynamics. Life Sci. (1994) 55(10):827–837.
   PubMed Web of Science ®Google Scholar
• •This animal study could demonstrate that chemically modified cell-free haemoglobin exerts different influences on systemic and regional organ blood flow in comparison to unmodified HBOC.
   Google Scholar
• SHERMAN IA, DLUGOSZ JA, PERELMAN V, HSIA CJ, WONG LT, CONDIE RM: Systemic hemodynamic and hepatic microvascular responses to a 33% blood volume exchange with whole blood, stroma-free hemoglobin, and oxypolyhemoglobin solutions. Biomater. Artif Cells Immobilization Biotechnol. (1993) 21(4):537–551.
   PubMed Web of Science ®Google Scholar
• NOLTE D, BOTZLAR A, PICKELMANN S, BOUSKELA E, MESSMER K: Effects of diaspirin-cross-linked hemoglobin (DCLHb) on the microcirculation of striated skin muscle in the hamster: a study on safety and toxicity. Lab. Clin. Med. (1997) 130(3):314–327.
   PubMedGoogle Scholar
• VON DOBSCHUETZ E, HOFFMANN T, MESSMER K: Diaspirin cross-linked hemoglobin effectively restores pancreatic microcirculatory failure in hemorrhagic shock. Anesthesiology (1999) 91(6):1754–1762.
   PubMed Web of Science ®Google Scholar
• ••Human cross-linked haemoglobinpreserved pancreatic microcirculation more effectively than whole blood after haemorrhagic shock in rats.
   Google Scholar
• STRATE T, KLEINHANS H, MANN 0 et al.: Therapy of microcirculatory dysfunction in acute pancreatitis with i.v. application of bovine hemoglobin in the rat. Gastroenterology (2000) 118(4):A302(1677).
   Google Scholar
• GLASGOW SC, SHAH AS, NOONE RB et al: Comparison of various hemoglobin polyoxyethylene conjugate solutions as resuscitative fluids after hemorrhagic shock. Trauma (2000) 48(5):884–892 (discussion 892–893).
   Google Scholar
• SIELENKAMPER AW, EICHELBRONNER 0, MARTIN CM, MAD ORIN SW, CHIN-YEE IH, SIBBALD WJ: Diaspirin cross-linked hemoglobin improves mucosal perfusion in the ileum of septic rats. Grit. Care Med. (2000) 28(3):782–787.
   PubMed Web of Science ®Google Scholar
• ••Systemic haemodynamics and microcirculatory perfusion in the ileum of septic rats were improved with cross-linked haemoglobin.
   Google Scholar
• HORN EP, STANDL T, WILHELM S et al.: Bovine hemoglobin increases skeletal muscle oxygenation during 95% artificial arterial stenosis. Surgery (1997) 121(4)411–418.
   Google Scholar
• •Increase of tissue oxygen tensions in the post-stenotic skeletal muscle was achieved with polymerised bovine haemoglobin solution.
   Google Scholar
• STANDL T, HORN EP, BURMEISTER MA et al: Bovine hemoglobin restores myocardial tissue tension in dogs with acute critical coronary stenosis and extended hemodilution. Anesthesiology (1999) 90:A697.
   PubMedGoogle Scholar
• COLE DJ, SCHELL RM, DRUMMOND JC, REYNOLDS L: Focal cerebral ischemia in rats. Effect of hypervolemic hemodilution with diaspirin cross-linked hemoglobin versus albumin on brain injury and edema. Anesthesiology (1993) 78(2)335–342.
   Google Scholar
• ••The degree of ischaemic brain damageafter middle cerebral artery occlusion in rats was reduced by haemodilution with cross-linked HBOC.
   Google Scholar
• MCKENZIE JE, COST EA, SCANDLING DM, AHLE NW, SAVAGE RW: Effects of diaspirin crosslinked haemoglobin during coronary angioplasty in the swine. Cardiovasc. Res. (1994) 28(8):1188–1192.
   PubMed Web of Science ®Google Scholar
• PICKELMANN S, NOLTE D, LEIDERER R, SCHUTZE E, MESSMER K: Attenuation of postischemic reperfusion injury in striated skin muscle by diaspirin-cross-linked Hb. Am. j Physiol (1998) 275(2 Pt 2):H361–8.
   Google Scholar
• HABLER 0, KLEEN M, PAPE A, MEISNER E KEMMING G, MESSMER K: Diaspirin-crosslinked hemoglobin reduces mortality of severe hemorrhagic shock in pigs with critical coronary stenosis. Grit. Care Med. (2000) 28(6):1889–1898.
   PubMed Web of Science ®Google Scholar
• ••Subendocardial ischaemia was reversed bycross-linked haemoglobin in pigs with critical LAD stenosis and haemorrhagic shock.
   Google Scholar
• CONHAIM RL, RODENKIRCH LA, WATSON KE, HARMS BA: Acellular hemoglobin solution enters compressed lung capillaries more readily than red blood cells. I Appl. Physiol (2000) 89(3):1198–1204.
   PubMed Web of Science ®Google Scholar
• ••This animal experiment shows withfluoroscopy that cell-free haemoglobin molecules are able to perfuse compressed capffiaries in lung zone I more readily than erythrocytes, offering the oppurtunity of improved gas exchange in critically ill individuals.
   Google Scholar
• BONE HG, SCHENARTS PJ, BOOKE M etal.: Oxalated pyridoxalated hemoglobin polyoxyethylene conjugate normalizes the hyperdynamic circulation in septic sheep. Grit. Care Med. (1997) 25(6):1010–1018.
   Google Scholar
• BONE HG, SCHENARTS PJ, FISCHER SR, MCGUIRE R, TRABER LD, TRABER DL: Pyridoxalated hemoglobin polyoxyethylene conjugate reverses hyperdynamic circulation in septic sheep. Appl. Physiol (1998) 84(6):1991–1999.
   PubMed Web of Science ®Google Scholar
• ••Chemically modified haemoglobin wasable to restore physiologic haemodynamic conditions in septic sheep.
   Google Scholar
• HERTZMAN CM, KEIPERT PE, CHANG TM: Serum antibody titers in rats receiving repeated small subcutaneous injections of hemoglobin or polyhemoglobin: a preliminary report. Int. J.Artif Organs (1986) 9(3):179–182.
   PubMed Web of Science ®Google Scholar
• ESTEP TN, GONDER J, BORNSTEIN I, AONO F: Immunogenicity of diaspirin cross-linked human hemoglobin solutions. Biomater. Artif Cells bramobil. Biotechnol (1992) 20(2-4):603–609.
   Google Scholar
• HAMILTON RG, KELLY N, GAWRYL MS, RENTKO VT: Absence of immunopathology associated with repeated IV administration of bovine Hb-based oxygen carrier in dogs. Transfusion (2001) 41(2):219–225.
   PubMed Web of Science ®Google Scholar
• •Multidose applications of polymerised bovine haemoglobin in dogs produced specific IgG after six weeks but no anaphylactic reactions or antibody-mediated deposition in kidney and liver.
   Google Scholar
• WHITE CT, MURRAY AJ, SMITH DJ, GREENE JR, BOLIN RB: Synergistic toxicity of endotoxin and hemoglobin. Lab. CBI]. Med. (1986) 108(2):132–137.
   PubMed Web of Science ®Google Scholar
• LANGERMANNS J, VUREN-VAN DER HULST M, BLEEKER W: Safety evaluation of a modified hemoglobin solution (PolyHbXL) in a murine infection model. Artif Cells Blood Substit. Immobil Biotechnol (1996) 24:376.
   Google Scholar
• SOLTERO R, LEPPANIEMI A, PIKOULIS E, RATIGAN J, WAASDORP C, MALCOLM D: Diaspirin crosslinked hemoglobin (DCLHb) increases rat skin wound breaking strength after hemorrhage. Artif Cells Blood Substit. Immobil Biotechnol (1996) 24:433.
   Google Scholar
• HUGHES GS, FRANCOME SF, ANTAL EJ etal.: Hematologic effects of a novel hemoglobin-based oxygen carrier in normal male and female subjects. I Lab. CBI]. Med. (1995) 126(5):444–451.
   Google Scholar
• CALLAS DD, CLARK TL, MOREIRA PL et al.: In vitro effects of a novel hemoglobin-based oxygen carrier on routine chemistry, therapeutic drug, coagulation, hematology, and blood bank assays. CM]. Chem. (1997) 43(9):1744–1748.
   Google Scholar
• BALION CM, CHAMPAGNE PA, ALI AC: Evaluation of HemogloBind for removal of o-rafflnose cross-linked hemoglobin (Hemolink) from serum. CBI]. Chem. (1997) 43(9):1796–1797.
   Google Scholar
• CHANCE JJ, NORRIS EJ, KROLL MH: Mechanism of interference of a polymerized hemoglobin blood substitute in an alkaline phosphatase method. Clin. Chem. (2000) 46(9):1331–1337.
   PubMed Web of Science ®Google Scholar
• PRZYBELSKI RJ, DAILY EK, KISICKI JC, MATTIA-GOLDBERG C, BOUNDS MJ, COLBURN WA: Phase I study of the safety and pharmacologic effects of diaspirin cross-linked hemoglobin solution. Grit. Care Med. (1996) 24(12):1993–2000.
   PubMed Web of Science ®Google Scholar
• SWAN SK, HALSTENSON CE, COLLINS AJ, COLBURN WA, BLUE J, PRZYBELSKI RJ: Pharmacologic profile of diaspirin cross-linked hemoglobin in hemodialysis patients. Am. I Kidney Dis. (1995) 26(6):918–923.
   PubMed Web of Science ®Google Scholar
• GARRIOCH MA, MCCLURE JH, WILDSMITH JA: Haemodynamic effects of diaspirin crosslinked haemoglobin (DCLHb) given before abdominal aortic aneurysm surgery. Br. I Ariaesth. (1999) 83(5)702–707.
   Google Scholar
• SAXENA R, WIJNHOUD AD, CARTON H et al: Controlled safety study of a hemoglobin-based oxygen carrier, DCLHb, in acute ischemic stroke. Stroke (1999) 30(5):993–996.
   PubMed Web of Science ®Google Scholar
• SLOAN EP, KOENIGSBERG M, GENS D et al.: Diaspirin cross-linked hemoglobin (DCLHb) in the treatment of severe traumatic hemorrhagic shock: a randomized controlled efficacy trial. JAMA (1999) 282(19):1857–1864.
   PubMed Web of Science ®Google Scholar
• KASPER SM, WALTER M, GRUNE F, BISCHOFF A, ERASMI H, BUZELLO W: Effects of a hemoglobin-based oxygen carrier (HBOC-201) on hemodynamics and oxygen transport in patients undergoing preoperative hemodilution for elective abdominal aortic surgery. Ariesth. Arialg. (1996) 83(5):921–927.
   PubMed Web of Science ®Google Scholar
• STANDL T, WILHELM S, HORN EP et al.: Preoperative hemodilution with bovine hemoglobin. Acute hemodynamic effects in liver surgery patients. Anaesthetist. (1997) 46(9):763–770.
   Google Scholar
• BRAUER E STANDL T, WILHELM S, BURMEISTER MA, SCHULTE AM ESCH J: Transcranial Doppler sonography mean flow velocity during infusion of ultrapurifled bovine hemoglobin. Neurosurg. Anesthesia (1998) 10(3):146–152.
   PubMed Web of Science ®Google Scholar
• ULATOWSKI JA, BUCCI E, NISHIKAWA T etal.: Cerebral 02 transport with hematocrit reduced by cross-linked hemoglobin transfusion. Am. Physiol (1996) 270(2 Pt 2):H466–475.
   Google Scholar
• LAMURAGLIA GM, O'HARA PJ, BAKER WH et al: The reduction of the allogenic transfusion requirement in aortic surgery with a hemoglobin-based solution. Vase. &mg. (2000) 31(2):299–308.
   Google Scholar
• •In this clinical setting, bovine HBOC could eliminate the need for allogeneic transfusion in 27% of patients undergoing infrarenal aortic reconstruction.
   Google Scholar